🔊Join the growing global ASCO PallOnc COP as we kick off the year nurturing old and new connections while gearing up for another successful year. DM for the zoom meeting link and to join our listserv. 🕒We can't wait to greet you all on Sep 29, 2026 @ 16:00 EST.

Still deciding on SIOG 2026? SIOG members pay a lower registration rate. Joining before you register can bring the cost down and gives you access to the community year-round. 5–7 Nov, Valencia. https://loom.ly/ITKRCJQ #SIOG2026 #GeriOnc #CancerCare

📰 The 2026 @eortc.org #QualityofLife Group (QLG) newsletter has arrived! Catch up on the latest QLG research and initiatives, including perspectives on the opportunities and challenges of AI in quality of life research. 🔗 qol.eortc.org/newsletters/ #GivingVoice2Patients #CancerResearch

Low Risk and Favorable Intermediate Risk for Prostate Cancer algorithm from @tylersbrt.bsky.social: myopenmedicine.com/algorithms/l...

Low Risk and Favorable Intermediate Risk for Prostate Cancer

Selection and follow-up for men with low-risk and select favorable intermediate-risk prostate cancer. Tyler Seibert, MD, PhD, Genitourinary Section Chief at UC San Diego Radiation Oncology outlines cr...

myopenmedicine.com

Our latest MATCH study publication is getting a lot of press - check it out! medicalxpress.com/news/2026-09...

Researchers find mind-body interventions ease symptoms, providing meaningful benefits after cancer treatment

The Mindfulness and Tai Chi for Cancer Health (MATCH) study looked at more than 500 cancer survivors with varying types and stages of cancer and found that patients experienced less pain, fatigue and ...

medicalxpress.com

Advance the science of oncology. As a JCO Journals reviewer, you can sharpen your own research skills while protecting the quality of cancer research. Earn CME credits and FASCO™ points. Learn more and become a reviewer today: https://bit.ly/3VvklTa #PeerReviewWeek

Cancer's impact knows no borders. Conquer Cancer has supported researchers in over 102 countries—representing about 52% of countries worldwide. Learn more at conquer.org.

Could biomarker selection broaden immunotherapy’s role in pancreatic cancer? A phase II trial evaluates cemiplimab + gemcitabine in metastatic #PDAC with SWI/SNF alterations. @bottalab.bsky.social @shawnabeynaike.bsky.social Read the article. https://bit.ly/4xS8V9V

Thank you ASCO member Dr. @fumikochino.bsky.social for speaking on the importance of federal cancer research funding! #ASCOAdvocacy continues to urge Congress to pass a full, bipartisan FY27 bill to provide the strongest possible investments in medical research.

The Battle for Cancer Research Funding: What You Need to Know

YouTube video by Money Matters Podcast | HFFG

youtube.com

What’s the optimal follow-up visit schedule for patients with #breastcancer? The latest ASCO guideline update recommends a risk-based approach. See the highlights in #ASCODailyNews: https://bit.ly/4xwJoUh

The add-on sessions at SIOG 2026 are how the conference gets off to a strong start. Five sessions on 5 November, pre-registration required and several run in parallel. Early bird open until 8 September. https://loom.ly/LBPOUSE #SIOG2026 #GeriOnc

What does bringing geriatric assessment into routine practice actually look like? This #SIOGwebinar on 5 August at 15:00 CEST has two clinicians sharing their experiences. Free, open to all. Register: https://loom.ly/svYTJsA #GeriatricOncology #GeriOnc

We are live today at 15:00 CEST. Geriatric assessment in routine cancer care. Free to join. Register: https://loom.ly/svYTJsA #GeriatricOncology #GeriOnc

Missed it live? The SIOG Webinar on geriatric assessment in routine cancer care is now on demand. https://loom.ly/QX6EvEA #GeriatricOncology #GeriOnc

ASCO is pleased to name Thomas E. Stinchcombe, MD, FASCO from @dukecancer.bsky.social as the new Editor-in-Chief of JCO, beginning January 2027. Dr. Stinchcombe’s expertise will drive innovation, faster publication timelines, and expanded global reach for high-impact cancer research.

A telehealth geriatric assessment and management intervention increased approach-oriented coping among older adults with metastatic cancer. https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70644

⏳ TIME IS RUNNING OUT! The IPOS Delphi Study on global psycho-oncology competencies closes August 21. Don't let international clinical standards be set without your expertise! Shape the future here: hku.au1.qualtrics.com/jfe/form/SV_...

Can treatment for intermediate-risk #Rhabdomyosarcoma be refined to improve local control while reducing long-term toxicity? Read the article: https://bit.ly/4q7tOvp

There’s no wrong way to experience #KCRS26, just the way that works best for you. However you attend, you'll be part of the community working to accelerate progress in #KidneyCancer research. Register today: https://bit.ly/KCRS26Registration #AcceleratingCures

People with SMI face inequities in cancer care and survival Equitable oncology requires integrated psychiatric care and system-level change @cacancerjournal.bsky.social #McFarland @kellyirwin25.bsky.social acsjournals.onlinelibrary.wiley.com/doi/10.3322/...

As a rural practitioner I thank Prof Anna Ugalde for the work she + team @deakinuniversity.bsky.social does on supportive care & bringing equitable cancer outcomes in rural and remote communities closer to reality. #MASCC26 @cancercaremascc.bsky.social @markbutlermp.bsky.social @theracp.bsky.social

Excited to be selected as a social media ambassador for #MASCC26! Looking forward to sharing the latest research in supportive care alongside my amazing colleagues from across the globe! Follow along! @cancercaremascc.bsky.social

👥 Registration opens at 3pm today for @cancercaremascc.bsky.social #MASCC26! 🩺 Can’t wait to see and learn alongside my colleagues & present on survivorship with @michael-jefford.bsky.social & #DrLarissaNekhlyudov! 🇦🇺 See you soon!

Loneliness interventions: Categories, examples, and end-of-life modifications. #geriatrics https://agsjournals.onlinelibrary.wiley.com/doi/10.1111/jgs.70542

Our new position statement outlines ways to expand eligibility, increase funding & expand community access for pediatric oncology clinical trials. Learn more: https://bit.ly/4v1q7J7 #ASCOAdvocacy

Less than 2 weeks to go! Webinar: High Risk of Fear of Cancer Recurrence June 15, 2026, 1 to 2 p.m. EDT Live Webcast FEATURING: 1. Lauren Rudy 2. Prof. Dr. Marije van der Lee 3. Dr. Sophie Lebel For more information and to register ipos-society.org/event-6683185

🎙 It's the final daily episode of #ASCO26! Dr. Monty Pal of @cityofhope.bsky.social provides his Top Takeaways on key Day 5 abstracts, available now on the #ASCODailyNews Podcast: https://bit.ly/3Rv9wPj

Heading home from #ASCO26 today! Put two dates for @ascocancer.bsky.social Quality Care Symposium on your calendar: 🚨Abstracts are due in 2 weeks 6/16/2026 📆 #ASCOQLTY26 is Friday-Saturday 10/16-17/2026 See you in Boston! www.asco.org/quality

Don’t miss our joint session w/ American Society of Preventive Oncology chaired by Dr Kimmie Ng of @danafarber.bsky.social & Dr Irene Su w panelists @crisbergerot.bsky.social & Dr. Tara Henderson of @luriechildrens.bsky.social on rising incidence of young adults w cancer. https://bit.ly/4e4idHY

The final study presented at #ASCO26 Plenary: RASolute-302 results show daraxonrasib meeting all primary and key secondary endpoints, demonstrating significant and clinically meaningful improvements in OS, PFS, and ORR in metastatic #PDAC: https://bit.ly/49r62n1 #ASCODailyNews